| CANDRIAM EQUITIES L BIOTECHNOLOGY C-H CAP EUR | BIOTECNOLOGÍA | 272,210000 | 01/04/2026 | 2,50% | 50,39% | *** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY I CAP EUR | BIOTECNOLOGÍA | 2.982,380000 | 01/04/2026 | 4,41% | 51,68% | *** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY I CAP USD | BIOTECNOLOGÍA | 7.011,641534 | 01/04/2026 | 4,63% | 51,71% | *** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY I-H CAP EUR | BIOTECNOLOGÍA | 2.852,140000 | 01/04/2026 | 2,67% | 51,28% | *** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY N CAP USD | BIOTECNOLOGÍA | 739,370961 | 01/04/2026 | 4,34% | 49,11% | *** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY R CAP EUR | BIOTECNOLOGÍA | 443,060000 | 01/04/2026 | 4,45% | 54,79% | *** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY R CAP USD | BIOTECNOLOGÍA | 337,363206 | 01/04/2026 | 4,67% | 54,79% | **** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY R-H CAP EUR | BIOTECNOLOGÍA | 288,280000 | 01/04/2026 | 2,72% | 54,25% | *** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY V CAP USD | BIOTECNOLOGÍA | 2.568,668677 | 01/04/2026 | 4,69% | 52,25% | *** |
| CANDRIAM EQUITIES L EMERGING MARKETS C CAP EUR | RVI EMERGENTES | 1.291,430000 | 02/04/2026 | 6,40% | 51,32% | **** |
